Contracts › 75N94019F00126
75N94019F00126: To Provide a Platform for the Inclusion of Patients With Down Syndrome Into the Pharmacology-Based Clinical Trials. the Goals Are to Recruit This Patient Population Into the Pediatric Trials Network Opportunistic Study Model and to Develop a Training
Awarded to Duke University by National Institutes of Health (NIH).
$6.8Mobligated
$6.8Mpotential value
31 July 2026current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75N94019F00126 |
|---|---|
| Vehicle | 75N94018D00003 |
| Awardee | Duke University |
| Awarding agency | National Institutes of Health (NIH) |
| Awarding office | NATIONAL INSTITUTES OF HEALTH NICHD |
| NAICS | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) |
| PSC | AN12 Health R&D Services; Health Care Services; Applied Research |
| Place of performance | NC |
| Period of performance | 12 September 2019 to 31 July 2026 |
| Potential end | 31 July 2026 |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 04 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541715 contracts · All expiring contracts · USASpending record